1.
J Cancer Res Ther
;
2008 Jan-Mar; 4(1): 42-3
Article
in English
| IMSEAR
| ID: sea-111424
ABSTRACT
Metastatic hepatocellular carcinoma (HCC) has an aggressive course with a very poor outcome. The common hematogenous metastatic sites are the lungs, bones, and adrenal glands. The chest wall is an extremely rare site of metastasis from HCC. We report a rare presentation in a gentleman, where the chest wall metastasis kept progressing in spite of treatment, without any evidence of a detectable primary.
Subject(s)
Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Humans , Liver Neoplasms/drug therapy , Male , Muscle Neoplasms/drug therapy , Thoracic Wall/pathology
2.
J Cancer Res Ther
;
2005 Jan-Mar; 1(1): 57-9
Article
in English
| IMSEAR
| ID: sea-111395
3.
Article
in English
| IMSEAR
| ID: sea-63644
ABSTRACT
Metastasis to the prostate is extremely uncommon. We report a 38-year-old man with sigmoid colon carcinoma, treated with surgery and adjuvant chemotherapy, who developed isolated metastasis to the prostate four years after initial treatment. He was treated with chemoradiation and remains disease-free three years after detection of metastasis.